Skip to content

SI-BONE, Inc. SIBN Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Globus Medical logo
Globus MedicalGMED
Medtronic logo
MedtronicMDT
Bioventus logo
BioventusBVS
3D Systems logo
3D SystemsDDD

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal)?
SI-BONE, Inc. (SIBN) reported accounts receivable, credit loss expense (reversal) of $90K in Q1 2026.
How has SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal) changed year-over-year?
SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal) decreased by 1.1% year-over-year, from $91K to $90K.
What is the long-term trend for SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal)?
Over 4 years (2021 to 2025), SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal) has grown at a 152.6% compound annual growth rate (CAGR), from $14K to $570K.